Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Nanoparticles

December 6, 2018 CD derivatives / Drug delivery / Events / Pharma applications

Opinion leaders of CD society getting together in Budapest

In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from

Continue reading

September 22, 2018 CD as API / Pharma applications

Therapeutic potential for cyclodextrin‐based macromolecular systems in NPC

A paper has just come out in Macromolecular Rapid Communications highlighting the potential benefits of cyclodextrin-based macromolecular systems as cholesterol-mopping

Continue reading

September 17, 2018 Drug delivery / Pharma applications

Cyclodextrin-containing polymer-camptothecin nanopharmaceutical. Clinical trials

Cyclodextrin-containing polymer (CDP) (represented by blue in the scheme) conjugated to camptothecin (CPT) (represented by red) forms 30-40-nm diameter nanoparticles

Continue reading

August 28, 2018 Drug delivery / Pharma applications / Supramolecular systems

Cyclodextrins as theranostics

The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments

Continue reading

July 30, 2018 CD derivatives

Phosphates of cyclodextrin polymers

The synthesis of β-CD polymer phosphate sodium salts was worked out to be used for coating of metal-organic framework (MOF)

Continue reading

Posts pagination

«Previous Posts 1 … 6 7 8

Recent Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Cyclodextrins in 3D and 4D printing
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • Future automobiles made from supramolecular polymers are reality?
  • A cyclodextrin polymer that could change the future of batteries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,471 other subscribers
Loading Comments...